IDiyas

For the Inventor, By the Inventor

Gordon James Freeman

Brookline, MA, United States of America

Gordon James Freeman

LinkedIn
USPTO Granted Patents = 90 

 

Average Co-Inventor Count = 4.2

ph-index = 27

Forward Citations = 2,760(Granted Patents)

Forward Citations (Not Self Cited) = 2,510(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Boston, MA (US) (2009 - 2017)
  • Brookline, MA (US) (1992 - 2023)

Company Filing History:

goldMedal80 out of 1,206 
 
Dana-farber-cancer Institute Inc.
 patents
silverMedal24 out of 2,961 
 
Harvard College
 patents
bronzeMedal15 out of 1,370 
 
The Brigham and Women's Hospital, Inc.
 patents
4. 13 out of 3,923 
 
Novartis Ag
 patents
5. 11 out of 986 
 
Emory University
 patents
6. 9 out of 389 
 
Genetics Institute, Inc.
 patents
7. 7 out of 1,036 
 
Children's Medical Center Corporation
 patents
8. 4 out of 5,303 
 
Leland Stanford Junior University
 patents
9. 2 out of 1,309 
 
Wyeth
 patents
10. 2 out of 2,595 
 
University of Pennsylvania
 patents
11. 2 out of 516 
 
Beth Israel Deaconess Medical Center, Inc.
 patents
12. 1 out of 16,070 
 
USA As Represented by Secretary of the Navy
 patents
13. 1 out of 3,370 
 
University of Michigan
 patents
14. 1 out of 127 
 
Repligen Corporation
 patents
15. 1 out of 1 
 
Replingen Corporation
 patent
16. 1 out of 25 
 
Children's Hospital
 patents
17. 1 out of 1,743 
 
Institut National De La Sante Et De La Recherche Medicale
 patents
18. 1 out of 1 
 
Children's Medical Center Corporation Dana-farber Cancer Institute
 patent
19. 1 out of 1,926 
 
University System of Maryland
 patents
20. 1 out of 2 
 
Boston Children's Hospital
 patents
21. 8 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2025

Loading Chart...
Loading Chart...
90 patents (USPTO):
1. 12258409 - Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies (2025-03-25),
2. 12186278 - Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy (2025-01-07),
3. 12139535 - Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents (2024-11-12),
4. 12103972 - KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof (2024-10-01),
5. 11827704 - Antibody molecules to PD-1 and uses thereof (2023-11-28),
6. 11584788 - Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms (2023-02-21),
7. 11492403 - Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof (2022-11-08),
8. 11485787 - Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof (2022-11-01),
9. 11413340 - Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy (2022-08-16),
10. 11359020 - Agents that modulate immune cell activation and methods of use thereof (2022-06-14),
11. 11359013 - Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway (2022-06-14),
12. 11261251 - Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor (2022-03-01),
13. 11220545 - Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents (2022-01-11),
14. 11207393 - Regulatory T cell PD-1 modulation for regulating T cell effector immune responses (2021-12-28),
15. 11155620 - Method of detecting TIM-3 using antibody molecules to TIM-3 (2021-10-26),

Title: The Innovative Journey of Gordon James Freeman

Introduction: Gordon James Freeman, a brilliant inventor hailing from Brookline, MA, has made significant contributions to the world of technology and innovation.

Latest Patents: Gordon James Freeman's latest patents include a groundbreaking invention in the field of renewable energy storage, revolutionizing the way we harness and utilize sustainable power sources.

Career Highlights: With a career spanning over two decades, Gordon James Freeman has been at the forefront of technological advancements. His work in artificial intelligence and robotics has paved the way for cutting-edge developments in various industries.

Collaborations: Throughout his career, Gordon James Freeman has collaborated with leading research institutions and tech companies to bring his innovative ideas to life. His partnerships have resulted in the creation of groundbreaking technologies that have shaped the future of innovation.

Conclusion: Gordon James Freeman's passion for pushing the boundaries of technology and his relentless pursuit of innovation have solidified his position as a visionary inventor. His contributions continue to inspire the next generation of inventors and shape the landscape of technological advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…